Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study

PURPOSE: Long-acting bronchodilators (LABD), in general, reduce respiratory symptoms, improve exercise endurance time and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). However, there might be heterogeneity in improvement for several outcomes on an individual level...

Descripción completa

Detalles Bibliográficos
Autores principales: Posthuma, Rein, Vanfleteren, Lowie E G W, Gaffron, Swetlana, Vaes, Anouk W, Franssen, Frits M E, Spruit, Martijn A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259581/
https://www.ncbi.nlm.nih.gov/pubmed/37313498
http://dx.doi.org/10.2147/COPD.S405478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259581/
https://www.ncbi.nlm.nih.gov/pubmed/37313498
http://dx.doi.org/10.2147/COPD.S405478

Ejemplares similares